Retrospective Evaluation of COVID-19 Infection and COVID-19 Vaccines in Heart Transplant Patients

Basit Öğe Kaydı
dc.authorscopusid57189350968
dc.authorscopusid57199151189
dc.authorscopusid35611300300
dc.authorscopusid40661114300
dc.authorscopusid6603075845
dc.authorscopusid7003267009
dc.authorscopusid55664567200
dc.contributor.authorKahraman, Ü.
dc.contributor.authorAkyol, D.
dc.contributor.authorÇiçek, C.
dc.contributor.authorBalcıoğlu, Ö.
dc.contributor.authorEngin, Ç.
dc.contributor.authorYağdı, T.
dc.contributor.authorTaşbakan, M.
dc.date.accessioned2024-08-25T18:32:09Z
dc.date.available2024-08-25T18:32:09Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground: Patients who have performed solid organ transplantation in terms of COVID-19 infection are included in the high-risk group. In this study, it was aimed to evaluate the relationship between vaccination and retrospective evaluation of 32 patients who underwent a heart transplant in the clinic and tested positive for SARS-CoV-2 polymerase chain reaction. Methods: In this study, demographic characteristics of the cases, comorbidities, timing of heart transplantation, immunosuppressive treatments, symptoms of COVID-19 infection, lung imaging findings, follow-up (outpatient/inpatient), treatments, 1-month mortality, and vaccination histories against COVID-19 infection were evaluated. The data obtained from the study were analyzed with SPSS version 25.0. Results: The 3 most common symptoms are cough (37.5%), myalgia (28.1%), and fever (21.8%). COVID-19 infection was severe in 6.2% of the patients, moderate in 37.5%, and mild in 56.2%. Hospitalization was required in 5 patients (15.6%, 1 in the intensive care unit), and the other patients were followed up as an outpatient. Severe COVID-19 infection was seen more in 33% of unvaccinated patients; 93.5% were vaccinated. Nineteen patients (68%) were vaccinated before COVID-19 infection. Our patients received the CoronoVac (Sinovac, China) vaccine. Conclusion: COVID-19 infection is more likely to be severe and mortal in patients with heart transplant recipients. It is also crucial to comply with preventive measures other than immunization in this group of patients. This study is the largest series investigating COVID-19 infection in heart transplant recipient patients in our country. © 2023 Elsevier Inc.en_US
dc.identifier.doi10.1016/j.transproceed.2023.04.033
dc.identifier.endpage1288en_US
dc.identifier.issn0041-1345
dc.identifier.issue5en_US
dc.identifier.pmid37271605en_US
dc.identifier.scopus2-s2.0-85163290044en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1283en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2023.04.033
dc.identifier.urihttps://hdl.handle.net/11454/100151
dc.identifier.volume55en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Inc.en_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectcoronovacen_US
dc.subjectSARS-CoV-2 vaccineen_US
dc.subjectSARS-CoV-2 vaccineen_US
dc.subjectadulten_US
dc.subjectArticleen_US
dc.subjectclinical articleen_US
dc.subjectclinical featureen_US
dc.subjectcomorbidityen_US
dc.subjectcontrolled studyen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectcorrelational studyen_US
dc.subjectcoughingen_US
dc.subjectdata analysisen_US
dc.subjectdemographicsen_US
dc.subjectdisease severityen_US
dc.subjectfemaleen_US
dc.subjectfeveren_US
dc.subjectfollow upen_US
dc.subjectheart transplantationen_US
dc.subjecthospitalizationen_US
dc.subjecthumanen_US
dc.subjectimmunosuppressive treatmenten_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectmortalityen_US
dc.subjectmyalgiaen_US
dc.subjectpolymerase chain reactionen_US
dc.subjectretrospective studyen_US
dc.subjectvaccinationen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectgraft recipienten_US
dc.subjectoutpatienten_US
dc.subjectSevere acute respiratory syndrome coronavirus 2en_US
dc.subjectCOVID-19en_US
dc.subjectCOVID-19 Vaccinesen_US
dc.subjectHeart Transplantationen_US
dc.subjectHumansen_US
dc.subjectOutpatientsen_US
dc.subjectRetrospective Studiesen_US
dc.subjectSARS-CoV-2en_US
dc.subjectTransplant Recipientsen_US
dc.titleRetrospective Evaluation of COVID-19 Infection and COVID-19 Vaccines in Heart Transplant Patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu